Evaluation of Candidate Theranostics for (227)Th/(89)Zr Paired Radioimmunotherapy of Lymphoma

(227)Th is a promising radioisotope for targeted α-particle therapy. It produces 5 α-particles through its decay, with the clinically approved (223)Ra as its first daughter. There is an ample supply of (227)Th, allowing for clinical use; however, the chemical challenges of chelating this large tetra...

Descripción completa

Detalles Bibliográficos
Autores principales: Abou, Diane S., Longtine, Mark, Fears, Amanda, Benabdallah, Nadia, Unnerstall, Ryan, Johnston, Hannah, Shim, Kyuhwan, Hasson, Abbie, Zhang, Hanwen, Ulmert, David, Mangin, Floriane, Ozen, Serife, Raibaut, Laurent, Brandès, Stéphane, Meyer, Michel, Chambron, Jean-Claude, Tatum, David S., Magda, Darren, Wahl, Richard L., Thorek, Daniel L.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2023
Materias:
Basic Science Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315695/
https://www.ncbi.nlm.nih.gov/pubmed/37142300
http://dx.doi.org/10.2967/jnumed.122.264979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315695/
https://www.ncbi.nlm.nih.gov/pubmed/37142300
http://dx.doi.org/10.2967/jnumed.122.264979

Ejemplares similares